Marrone Bio Innovations’ almond bloom solutions increase farmer ROI and support new Almond Orchard 2025 Goals
DAVIS, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) — Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), a leading developer of biological […]
IEC Announces Fiscal 2019 First Quarter Results
NEWARK, New York, Feb. 06, 2019 (GLOBE NEWSWIRE) — IEC Electronics Corp. (NYSE American: IEC) today announced results for the […]
CoreCivic Announces 2018 Fourth Quarter Earnings Release and Conference Call Dates
NASHVILLE, Tenn., Feb. 06, 2019 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (the Company) announced today that it will release […]
Wolverine World Wide Announces Fourth Quarter and Full-Year 2018 Conference Call for February 20, 2019
ROCKFORD, Mich., Feb. 06, 2019 (GLOBE NEWSWIRE) — Wolverine World Wide, Inc. (NYSE: WWW) today announced that it expects to […]
Orgenesis’ CSO Sara Ferber to Present to the International Research Training Group Hosted by Technische Universität Dresden and the King's College London
GERMANTOWN, Md., Feb. 06, 2019 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS), a developer of advanced cell therapies, manufacturer and […]
Corvus Presents Updated Biomarker and Clinical Results from Lead Pipeline Programs CPI-444 and CPI-006 at Immuno-Oncology 360° Conference
BURLINGAME, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company focused on the […]
Vodafone Germany Transforms Broadband Network Infrastructure with Casa Systems
Casa’s DOCSIS® 3.1-based solution paves the way for Vodafone to deliver gigabit speeds to millions of customers across the country […]
Veru to Report Fiscal 2019 First-Quarter Financial Results, Host Conference Call on February 13th
MIAMI, Feb. 06, 2019 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines […]
Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia
On track to initiate Phase III trial in H1 2019 NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) — Eyenovia, Inc. […]
resTORbio Appoints Erkan Baloglu, Ph.D., M.B.A., as Vice President of Drug Discovery and Medicinal Chemistry
BOSTON, Feb. 06, 2019 (GLOBE NEWSWIRE) — resTORbio, Inc. (Nasdaq:TORC), a clinical-stage biopharmaceutical company developing a new class of medicines […]
